175 related articles for article (PubMed ID: 38103056)
1. Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock.
Leisman DE; Handisides DR; Chawla LS; Albertson TE; Busse LW; Boldt DW; Deane AM; Gong MN; Ham KR; Khanna AK; Ostermann M; McCurdy MT; Thompson BT; Tumlin JS; Adams CD; Hodges TN; Bellomo R
Ann Intensive Care; 2023 Dec; 13(1):128. PubMed ID: 38103056
[TBL] [Abstract][Full Text] [Related]
2. ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock.
Leisman DE; Handisides DR; Busse LW; Chappell MC; Chawla LS; Filbin MR; Goldberg MB; Ham KR; Khanna AK; Ostermann M; McCurdy MT; Adams CD; Hodges TN; Bellomo R;
Crit Care; 2024 Apr; 28(1):130. PubMed ID: 38637829
[TBL] [Abstract][Full Text] [Related]
3. Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
Wieruszewski PM; Bellomo R; Busse LW; Ham KR; Zarbock A; Khanna AK; Deane AM; Ostermann M; Wunderink RG; Boldt DW; Kroll S; Greenfeld CR; Hodges T; Chow JH;
Crit Care; 2023 May; 27(1):175. PubMed ID: 37147690
[TBL] [Abstract][Full Text] [Related]
4. [Effect of different transpulmonary pressures guided mechanical ventilation on respiratory and hemodynamics of patients with ARDS: a prospective randomized controlled trial].
Li J; Luo Z; Li X; Huang Z; Han J; Li Z; Zhou Z; Chen H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):39-44. PubMed ID: 28459402
[TBL] [Abstract][Full Text] [Related]
5. Prognostic classification based on P/F and PEEP in invasively ventilated ICU patients with hypoxemia-insights from the MARS study.
Simonis FD; Schouten LRA; Cremer OL; Ong DSY; Amoruso G; Cinella G; Schultz MJ; Bos LD;
Intensive Care Med Exp; 2020 Dec; 8(Suppl 1):43. PubMed ID: 33336322
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock.
Bellomo R; Wunderink RG; Szerlip H; English SW; Busse LW; Deane AM; Khanna AK; McCurdy MT; Ostermann M; Young PJ; Handisides DR; Chawla LS; Tidmarsh GF; Albertson TE
Crit Care; 2020 Feb; 24(1):43. PubMed ID: 32028998
[TBL] [Abstract][Full Text] [Related]
7. The impacts of baseline ventilator parameters on hospital mortality in acute respiratory distress syndrome treated with venovenous extracorporeal membrane oxygenation: a retrospective cohort study.
Wu MY; Chang YS; Huang CC; Wu TI; Lin PJ
BMC Pulm Med; 2017 Dec; 17(1):181. PubMed ID: 29221484
[TBL] [Abstract][Full Text] [Related]
8. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of effect of norepinephrine and terlipressin on patients with ARDS combined with septic shock: a prospective single-blind randomized controlled trial].
Chen Z; Zhou P; Lu Y; Yang C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):111-116. PubMed ID: 28625256
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. P/FP ratio: incorporation of PEEP into the PaO
Palanidurai S; Phua J; Chan YH; Mukhopadhyay A
Ann Intensive Care; 2021 Aug; 11(1):124. PubMed ID: 34370116
[TBL] [Abstract][Full Text] [Related]
12. [Continuous prone position ventilation in patients with severe acute respiratory distress syndrome at high altitude].
Han J; Ma S; Sun B; Wang H; Sun X; Jia G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):161-164. PubMed ID: 33729133
[TBL] [Abstract][Full Text] [Related]
13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
14. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
15. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II for the Treatment of Vasodilatory Shock.
Khanna A; English SW; Wang XS; Ham K; Tumlin J; Szerlip H; Busse LW; Altaweel L; Albertson TE; Mackey C; McCurdy MT; Boldt DW; Chock S; Young PJ; Krell K; Wunderink RG; Ostermann M; Murugan R; Gong MN; Panwar R; Hästbacka J; Favory R; Venkatesh B; Thompson BT; Bellomo R; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Deane AM;
N Engl J Med; 2017 Aug; 377(5):419-430. PubMed ID: 28528561
[TBL] [Abstract][Full Text] [Related]
17. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
Needham CJ; Brindley PG
Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
[TBL] [Abstract][Full Text] [Related]
18. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.
Dellinger RP; Zimmerman JL; Taylor RW; Straube RC; Hauser DL; Criner GJ; Davis K; Hyers TM; Papadakos P
Crit Care Med; 1998 Jan; 26(1):15-23. PubMed ID: 9428538
[TBL] [Abstract][Full Text] [Related]
19. Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.
Bellomo R; Forni LG; Busse LW; McCurdy MT; Ham KR; Boldt DW; Hästbacka J; Khanna AK; Albertson TE; Tumlin J; Storey K; Handisides D; Tidmarsh GF; Chawla LS; Ostermann M
Am J Respir Crit Care Med; 2020 Nov; 202(9):1253-1261. PubMed ID: 32609011
[No Abstract] [Full Text] [Related]
20. Trajectory of PaO
Wieruszewski PM; Coleman PJ; Levine AR; Davison D; Smischney NJ; Kethireddy S; Guo Y; Hecht J; Mazzeffi MA; Chow JH
J Intensive Care Med; 2023 Oct; 38(10):939-948. PubMed ID: 37161301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
